-
OTC DXM drives good bargain - saving healthcare $31 billion over 10 years
WASHINGTON - The OTC availability of dextromethorphan will save consumers and the healthcare system between $22 billion and $31 billion over the next 10 years, according to a study released Tuesday that was conducted by Charles River Associates and quantifies the savings consumers and the healthcare system receive from the over-the-counter availability of the widely used cough suppressant.